These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The nosology of tardive syndromes. Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810 [TBL] [Abstract][Full Text] [Related]
23. Tardive dystonia, a case report. Veras AB; Rozenthal M; Nardi AE Braz J Psychiatry; 2006 Jun; 28(2):160-1. PubMed ID: 16810405 [No Abstract] [Full Text] [Related]
24. Use of clozapine in tardive dystonia. Van Harten PN; Kampuis DJ; Matroos GE Prog Neuropsychopharmacol Biol Psychiatry; 1996 Feb; 20(2):263-74. PubMed ID: 8861192 [TBL] [Abstract][Full Text] [Related]
25. Tardive Blepharospasm and Meige Syndrome during Treatment with Quetiapine and Olanzapine. Kiliç A; Erten E; Özdemir A Noro Psikiyatr Ars; 2015 Jun; 52(2):207-209. PubMed ID: 28360708 [TBL] [Abstract][Full Text] [Related]
26. Clinical comparison of tardive and idiopathic cervical dystonia. Molho ES; Feustel PJ; Factor SA Mov Disord; 1998 May; 13(3):486-9. PubMed ID: 9613742 [TBL] [Abstract][Full Text] [Related]
27. A review of 32 cases of tardive dystonia. Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236 [TBL] [Abstract][Full Text] [Related]
28. [Medical aspects of the medical treatment in dystonia]. Grabli D; Vidailhet M Bull Acad Natl Med; 2011; 195(4-5):935-50. PubMed ID: 22375361 [TBL] [Abstract][Full Text] [Related]
29. Managing antipsychotic-induced tardive dyskinesia. Gardos G Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074 [TBL] [Abstract][Full Text] [Related]
30. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management. Pierre JM Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025 [TBL] [Abstract][Full Text] [Related]
32. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958 [TBL] [Abstract][Full Text] [Related]
33. Olanzapine-induced Concurrent Tardive Dystonia and Tardive Dyskinesia in Schizophrenia with Intellectual Disability: A Case Report. Choe YM; Kim SY; Choi IG; Suh GH; Lee DY; Lee BC; Kim JW Clin Psychopharmacol Neurosci; 2020 Nov; 18(4):627-630. PubMed ID: 33124596 [TBL] [Abstract][Full Text] [Related]
34. Medical therapy and botulinum toxin in dystonia. Jankovic J Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914 [No Abstract] [Full Text] [Related]
35. On muscle spindles, dystonia and botulinum toxin. Rosales RL; Dressler D Eur J Neurol; 2010 Jul; 17 Suppl 1():71-80. PubMed ID: 20590812 [TBL] [Abstract][Full Text] [Related]
36. Treatment of tardive dyskinesia: use of dopamine-depleting agents. Fahn S Clin Neuropharmacol; 1983 Jun; 6(2):151-8. PubMed ID: 6133619 [TBL] [Abstract][Full Text] [Related]
37. Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics: a cross-sectional and retrospective study. Ryu S; Yoo JH; Kim JH; Choi JS; Baek JH; Ha K; Kwon JS; Hong KS J Clin Psychopharmacol; 2015 Feb; 35(1):13-21. PubMed ID: 25485636 [TBL] [Abstract][Full Text] [Related]